Endometriosis: An Immunologist’s Perspective
International Journal of Molecular Sciences · 28.05.2025 · 26 (11) · 5193
DOI: 10.3390/ijms26115193 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.05.2025. Verfasst von Jenny Valentina Garmendia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 449 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Cancer Research, SALVAGE, EATRIS-CZ.
Abstract (Originalsprache)
Endometriosis, a complex inflammatory disease, affects a significant proportion of women of reproductive age, approximately 10–15%. The disease involves the growth of endometrial glands and stroma outside the uterine cavity, leading to tissue remodeling and fibrosis. Hormonal imbalances, accompanied by local and general inflammation and pain, are key features of endometriosis. Endometriotic lesions are associated with the overproduction of cytokines, metalloproteinases, prostaglandins, reactive oxygen radicals, and extracellular vesicles. Genetic predisposition and cytokine gene polymorphisms have been documented. Macrophages, dendritic cells, mast cells, Th1 in the early phase, Th2 in the late phase, and T regulatory cells play a crucial role in endometriosis. Reduced NK cell function and impaired immune vigilance contribute to endometrial growth. The strong inflammatory condition of the endometrium poses a barrier to the proper implantation of the zygote, contributing to the infertility of these patients. Cytokines from various cell types vary with the severity of the disease. The role of microbiota in endometriosis is still under study. Endometriosis is associated with autoimmunity and ovarian cancer. Hormonal treatments and surgery are commonly used; however, recent interest focuses on anti-inflammatory and immunomodulatory therapies, including cytokine and anti-cytokine antibodies. Modulating the immune response has proven critical; however, more research is needed to optimize treatment for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
- Czech Advanced Technologies and Research Institute (CATRIN), Institute of Molecular and Translational Medicine, Palacky University, 779 00 Olomouc, Czech Republic.
- Laboratory of Experimental Medicine, University Hospital Olomouc, 779 00 Olomouc, Czech Republic.
ORCID-Profile: Jenny Valentina Garmendia, Claudia Valentina De Sanctis, Marian Hajdúch, Juan Bautista De Sanctis
Förderung
- National Institute for Cancer Research
- SALVAGE
- EATRIS-CZ
- National Institute of Virology and Bacteriology Project
Zitieren
APA
Garmendia, J. V., De Sanctis, C. V., Hajdúch, M., & De Sanctis, J. B. (2025). Endometriosis: An Immunologist’s Perspective. International Journal of Molecular Sciences, 26(11), 5193. https://doi.org/10.3390/ijms26115193
Vancouver
Garmendia JV, De Sanctis CV, Hajdúch M, De Sanctis JB. Endometriosis: An Immunologist’s Perspective. International Journal of Molecular Sciences. 2025;26(11):5193. doi:10.3390/ijms26115193
BibTeX
@article{Garmendia2025,
author = {Garmendia, Jenny Valentina and De Sanctis, Claudia Valentina and Hajdúch, Marian and De Sanctis, Juan Bautista},
title = {Endometriosis: An Immunologist’s Perspective},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {11},
pages = {5193},
doi = {10.3390/ijms26115193}
}
EUVIMED